Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 55.74
+0.20 (0.36%)
At close: Sep 16, 2026
SHA:688192 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 179.14 | 291.42 | 250.16 | 74.2 | 121.67 | 364.24 |
Trading Asset Securities | 1,557 | 1,645 | 589.83 | 674 | 1,295 | 1,711 |
Cash & Short-Term Investments | 1,736 | 1,936 | 839.99 | 748.2 | 1,416 | 2,075 |
Cash Growth | -22.87% | 130.51% | 12.27% | -47.18% | -31.74% | 246.26% |
Accounts Receivable | 210.67 | 143.44 | 27.49 | 48.04 | - | 7.55 |
Receivables | 210.67 | 143.44 | 27.49 | 48.04 | - | 7.55 |
Inventory | 42.9 | 36.95 | 44.11 | 23.47 | 5.07 | - |
Other Current Assets | 67.71 | 66.03 | 87.37 | 90.65 | 51.64 | 29.57 |
Total Current Assets | 2,057 | 2,183 | 998.97 | 910.36 | 1,473 | 2,112 |
Property, Plant & Equipment | 366.95 | 381.23 | 243.91 | 102.26 | 103.66 | 104.48 |
Other Intangible Assets | 379.89 | 396.43 | 429.85 | 461.98 | 492.02 | 474.9 |
Long-Term Deferred Charges | 2.89 | 4.09 | 8.62 | 16.99 | 7.99 | 4.54 |
Other Long-Term Assets | 40.83 | 38.09 | 37.38 | 4.79 | 5.06 | 49.51 |
Total Assets | 2,848 | 3,003 | 1,719 | 1,496 | 2,082 | 2,746 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 30.87 | 34.82 | 20.39 | 18.57 | 8.81 | 1.65 |
Accrued Expenses | 283.48 | 331.8 | 245.07 | 182.18 | 208.53 | 182.75 |
Short-Term Debt | 48.91 | 217.45 | 373.83 | 200.11 | - | - |
Current Portion of Long-Term Debt | 358.84 | 291.97 | 41.27 | 0.1 | - | - |
Current Portion of Leases | 22.75 | 21.2 | 23.53 | 22.95 | 21.34 | 16.84 |
Current Income Taxes Payable | 0.65 | 1.34 | - | 0.05 | 0 | - |
Current Unearned Revenue | 8.85 | 5.5 | 2.93 | 0.98 | - | - |
Other Current Liabilities | 28.84 | 81.14 | 78.06 | 23.49 | 9.82 | 10.76 |
Total Current Liabilities | 783.19 | 985.23 | 785.08 | 448.44 | 248.49 | 211.99 |
Long-Term Debt | 913.17 | 688.15 | 683.76 | 138.31 | - | - |
Long-Term Leases | 11.44 | 21.98 | 34.99 | 48.89 | 63.93 | 70.92 |
Long-Term Unearned Revenue | 10.94 | 11.48 | 14.84 | 12.11 | 11 | - |
Total Liabilities | 1,719 | 1,707 | 1,519 | 647.75 | 323.43 | 282.91 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 465.17 | 461.19 | 417.65 | 408.15 | 407.16 | 404.18 |
Additional Paid-In Capital | 4,999 | 4,956 | 3,136 | 2,954 | 2,757 | 2,729 |
Retained Earnings | -4,334 | -4,124 | -3,360 | -2,514 | -1,406 | -669.85 |
Total Common Equity | 1,130 | 1,294 | 193.76 | 848.63 | 1,758 | 2,463 |
Minority Interest | -0.89 | 1.83 | 6.3 | - | - | - |
Shareholders' Equity | 1,129 | 1,296 | 200.06 | 848.63 | 1,758 | 2,463 |
Total Liabilities & Equity | 2,848 | 3,003 | 1,719 | 1,496 | 2,082 | 2,746 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,355 | 1,241 | 1,157 | 410.37 | 85.27 | 87.76 |
Net Cash (Debt) | 380.92 | 695.51 | -317.39 | 337.83 | 1,331 | 1,987 |
Net Cash Growth | -64.49% | - | - | -74.62% | -33.02% | 231.62% |
Net Cash Per Share | 0.82 | 1.56 | -0.77 | 0.83 | 3.29 | 5.52 |
Filing Date Shares Outstanding | 465.17 | 461.19 | 417.65 | 408.15 | 407.16 | 404.18 |
Total Common Shares Outstanding | 465.17 | 461.19 | 417.65 | 408.15 | 407.16 | 404.18 |
Working Capital | 1,274 | 1,197 | 213.89 | 461.93 | 1,225 | 1,900 |
Book Value Per Share | 2.43 | 2.81 | 0.46 | 2.08 | 4.32 | 6.09 |
Tangible Book Value | 750.12 | 897.43 | -236.09 | 386.65 | 1,266 | 1,988 |
Tangible Book Value Per Share | 1.61 | 1.95 | -0.57 | 0.95 | 3.11 | 4.92 |
Buildings | 227.15 | 227.2 | - | - | - | - |
Machinery | 167.89 | 160.67 | 55.43 | 49.14 | 31.99 | 26.91 |
Construction In Progress | - | - | 169.72 | 13.35 | 8.85 | 5.04 |